Enhancement of buoyant properties of gastroretentive dosage forms through nanosponge-based formulations

Objective(s): This study aimed to develop floating tablets of an insoluble weak acidic drug. The study protocol objective was to prepare the tablets using two forms of active pharmaceutical ingredient (API): the pure form and the modified nanosponge form.Materials and Methods: Lamotrigine was used a...

Full description

Saved in:
Bibliographic Details
Main Authors: Naga Raju Kandukoori, Kethavath Jhansi, Deepika B, Venkat Ratnam Devadasu, Katla Venu Madhav
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2025-07-01
Series:Nanomedicine Journal
Subjects:
Online Access:https://nmj.mums.ac.ir/article_26003_61dc3bfc03db7f5ba65bbf0c368bba72.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850076228427448320
author Naga Raju Kandukoori
Kethavath Jhansi
Deepika B
Venkat Ratnam Devadasu
Katla Venu Madhav
author_facet Naga Raju Kandukoori
Kethavath Jhansi
Deepika B
Venkat Ratnam Devadasu
Katla Venu Madhav
author_sort Naga Raju Kandukoori
collection DOAJ
description Objective(s): This study aimed to develop floating tablets of an insoluble weak acidic drug. The study protocol objective was to prepare the tablets using two forms of active pharmaceutical ingredient (API): the pure form and the modified nanosponge form.Materials and Methods: Lamotrigine was used as API and other ingredients used were HPMC, Xanthan gum, Magnesium stearate etc. The physicochemical properties of all the prepared tablets were tested, and the results were found to comply with the standards. Gastroretentive (GR) characteristics, such as floating lag time and duration, were recorded and compared.Results: The formulations containing the pure form of the drug (F1 to F4) exhibited longer floating lag times and shorter floating durations, whereas the tablets containing the nanosponge form of the drug (F5 to F8) showed improved buoyant properties, evidenced by shorter lag times and longer floating durations. All formulations were evaluated for in-vitro drug release, with a higher percentage of drug dissolution observed in the nanosponge-based formulations.Conclusion: These results highlight the importance of modifying the physical form of an insoluble drug to enhance both buoyancy and drug release properties in gastroretentive tablet dosage forms.
format Article
id doaj-art-d098a33a633144afbc1e7c3d72350825
institution DOAJ
issn 2322-3049
2322-5904
language English
publishDate 2025-07-01
publisher Mashhad University of Medical Sciences
record_format Article
series Nanomedicine Journal
spelling doaj-art-d098a33a633144afbc1e7c3d723508252025-08-20T02:46:04ZengMashhad University of Medical SciencesNanomedicine Journal2322-30492322-59042025-07-0112350050610.22038/nmj.2025.86211.216626003Enhancement of buoyant properties of gastroretentive dosage forms through nanosponge-based formulationsNaga Raju Kandukoori0Kethavath Jhansi1Deepika B2Venkat Ratnam Devadasu3Katla Venu Madhav4Department of Pharmaceutics, St. Pauls College of Pharmacy, Hyderabad, Telangana, India.Department of Pharmaceutics, St. Pauls College of Pharmacy, Hyderabad, Telangana, India.Department of Pharmaceutics, St. Pauls College of Pharmacy, Hyderabad, Telangana, India.Department of Pharmaceutics, St. Pauls College of Pharmacy, Hyderabad, Telangana, India.Department of Pharmaceutics, St. Pauls College of Pharmacy, Hyderabad, Telangana, India.Objective(s): This study aimed to develop floating tablets of an insoluble weak acidic drug. The study protocol objective was to prepare the tablets using two forms of active pharmaceutical ingredient (API): the pure form and the modified nanosponge form.Materials and Methods: Lamotrigine was used as API and other ingredients used were HPMC, Xanthan gum, Magnesium stearate etc. The physicochemical properties of all the prepared tablets were tested, and the results were found to comply with the standards. Gastroretentive (GR) characteristics, such as floating lag time and duration, were recorded and compared.Results: The formulations containing the pure form of the drug (F1 to F4) exhibited longer floating lag times and shorter floating durations, whereas the tablets containing the nanosponge form of the drug (F5 to F8) showed improved buoyant properties, evidenced by shorter lag times and longer floating durations. All formulations were evaluated for in-vitro drug release, with a higher percentage of drug dissolution observed in the nanosponge-based formulations.Conclusion: These results highlight the importance of modifying the physical form of an insoluble drug to enhance both buoyancy and drug release properties in gastroretentive tablet dosage forms.https://nmj.mums.ac.ir/article_26003_61dc3bfc03db7f5ba65bbf0c368bba72.pdffloatationgastric residencelamotriginesponge meshesxanthan gum
spellingShingle Naga Raju Kandukoori
Kethavath Jhansi
Deepika B
Venkat Ratnam Devadasu
Katla Venu Madhav
Enhancement of buoyant properties of gastroretentive dosage forms through nanosponge-based formulations
Nanomedicine Journal
floatation
gastric residence
lamotrigine
sponge meshes
xanthan gum
title Enhancement of buoyant properties of gastroretentive dosage forms through nanosponge-based formulations
title_full Enhancement of buoyant properties of gastroretentive dosage forms through nanosponge-based formulations
title_fullStr Enhancement of buoyant properties of gastroretentive dosage forms through nanosponge-based formulations
title_full_unstemmed Enhancement of buoyant properties of gastroretentive dosage forms through nanosponge-based formulations
title_short Enhancement of buoyant properties of gastroretentive dosage forms through nanosponge-based formulations
title_sort enhancement of buoyant properties of gastroretentive dosage forms through nanosponge based formulations
topic floatation
gastric residence
lamotrigine
sponge meshes
xanthan gum
url https://nmj.mums.ac.ir/article_26003_61dc3bfc03db7f5ba65bbf0c368bba72.pdf
work_keys_str_mv AT nagarajukandukoori enhancementofbuoyantpropertiesofgastroretentivedosageformsthroughnanospongebasedformulations
AT kethavathjhansi enhancementofbuoyantpropertiesofgastroretentivedosageformsthroughnanospongebasedformulations
AT deepikab enhancementofbuoyantpropertiesofgastroretentivedosageformsthroughnanospongebasedformulations
AT venkatratnamdevadasu enhancementofbuoyantpropertiesofgastroretentivedosageformsthroughnanospongebasedformulations
AT katlavenumadhav enhancementofbuoyantpropertiesofgastroretentivedosageformsthroughnanospongebasedformulations